The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Share News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Consort Medical First Half Profit Falls Due To Cramlington Incident

Tue, 03rd Dec 2019 09:14

(Alliance News) - Consort Medical PLC on Tuesday said its interim profit was considerably smaller following an incident at its Aesica Cramlington manufacturing facility.

Consort's pretax profit for the six months ended October 31 was GBP1.2 million, far less than the GBP9.6 million profit posted the year before as revenue fell 4.3% to GBP146.0 million from GBP152.5 million.

This was primarily caused by the Cramlington incident, in which a small area of the Northumberland-based operating plant was damaged in what was described by Consort at the time as "the rapid thermal degradation of a chemical resulting in the expulsion of material and contamination of the facility".

This hurt the performance of its active pharmaceutical ingredients and finished dose manufacturing unit, Aesica, where revenue fell 11% to GBP81.1 million from GBP90.9 million.

Bespak, Consort's drug delivery devices unit, was unaffected, with revenue up 5.4% at GBP64.9 million versus GBP61.6 million the year prior.

On November 18, following the end of its first half, contract development and manufacturing pharmaceutical company Consort agreed to a GBP505 million bid from Swedish peer Recipharm AB. Recipharm will pay 1,010 pence in cash for each Consort share. The proposed deal implies an enterprise value of GBP627 million for Consort.

Given that Recipharm may reduce its acquisition consideration if any dividend or other distribution is made by the Hemel Hempstead-based company, Consort has opted not to declare an interim dividend.

Consort Chief Executive Jonathan Glenn said: "The board's expectations for the full year remain unchanged. We anticipate that the group's performance in the second half of the year will benefit from continued growth in Bespak, recommencing manufacture of the specific product involved in the Cramlington incident and a reduction in the backlog at Aesica.

"The group is subject to a recommended offer from Recipharm Holdings Ltd. The board remains confident of Consort's future prospects."

Shares in Consort were down 0.5% at 1,040.00 pence in London on Tuesday morning.

By Anna Farley; annafarley@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
18 Nov 2019 10:50

ShoreCap downgrades Consort Medical to 'hold' after all-cash offer from Recipharm

(Sharecast News) - Analysts at ShoreCap downgraded their recommendation for shares of Consort Medical from 'buy' to 'hold' following the recommended cash offer from Recipharm.

Read more
18 Nov 2019 10:22

UK WINNERS & LOSERS SUMMARY: Consort Medical Rises On Takeover Offer

UK WINNERS & LOSERS SUMMARY: Consort Medical Rises On Takeover Offer

Read more
18 Nov 2019 10:13

UPDATE 2-Election polls thrust UK midcaps to 14-month high

* FTSE 100 up 0.1%, FTSE 250 up 0.2%* Aviva steepest decliner on main board* Pound gains on election hopes* IQE tanks after results warning* Buyout offer spurs Consort Medical (Adds news items, updates to closing prices)By Muvija M and Shashwat Awas...

Read more
18 Nov 2019 09:05

UPDATE 1-Sweden's Recipharm agrees to buy Britain's Consort Medical for 505 mln pounds

(Adds detail, background, share reactions)Nov 18 (Reuters) - Swedish pharmaceutical group Recipharm has agreed to buy British peer Consort Medical for 505 million pounds or 6.3 billion crowns ($649 million), the companies said on Monday.They said ...

Read more
18 Nov 2019 08:43

LONDON MARKET OPEN: Trade Hopes Lift Stocks; UK Election Pledges Flow

LONDON MARKET OPEN: Trade Hopes Lift Stocks; UK Election Pledges Flow

Read more
18 Nov 2019 08:38

TOP NEWS: Consort Medical Shares Rocket On GBP505 Million Buyout Offer

TOP NEWS: Consort Medical Shares Rocket On GBP505 Million Buyout Offer

Read more
18 Nov 2019 08:07

LONDON BRIEFING: Sage And Consort Medical Add To Run Of M&A Activity

LONDON BRIEFING: Sage And Consort Medical Add To Run Of M&A Activity

Read more
18 Nov 2019 07:42

LONDON MARKET PRE-OPEN: China-US Trade Talks Positive But Lower Call

LONDON MARKET PRE-OPEN: China-US Trade Talks Positive But Lower Call

Read more
4 Nov 2019 16:39

Invesco Reduces Holding In Consort Medical After Transaction

Invesco Reduces Holding In Consort Medical After Transaction

Read more
18 Oct 2019 16:06

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
18 Oct 2019 12:53

Friday broker round-up

(Sharecast News) - Royal Bank of Scotland: JP Morgan upgrades to overweight with a target price of 280p.

Read more
18 Oct 2019 10:19

Consort Medical signs VapourSoft agreement with Regeneron

(Sharecast News) - Consort Medical on Friday entered into a development agreement to incorporate its VapourSoft technology into a drug delivery device in partnership with Regeneron Pharmaceuticals.

Read more
18 Oct 2019 08:13

Consort Medical Signs VapourSoft Development Agreement With Regeneron

Consort Medical Signs VapourSoft Development Agreement With Regeneron

Read more
11 Sep 2019 10:27

WINNERS & LOSERS SUMMARY: LSE Up After Merger Bid From Hong Kong Rival

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - WINNERS----------London up a

Read more
11 Sep 2019 09:58

Consort Medical Decontamination Delay To Worsen Profit Impact

(Alliance News) - Consort Medical PLC on Wednesday said full-year profit could be hurt by up to GBP9.0 million, following an incident at a company facility in Northumberland.In July, a area

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.